Compare AstraZeneca plc (AZN) vs Cronos Group Inc (CRON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Cronos Group Inc — how do they compare? AstraZeneca plc trades at $158.03 (market cap $248.14B), while Cronos Group Inc trades at $3.08 (market cap $1.14B). The key difference: AstraZeneca plc is far larger — about 217.7× Cronos Group Inc's market cap, and AstraZeneca plc pays a 2.01% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| AZN | CRON | |
|---|---|---|
Market Cap | $248.14B | $1.14B |
Sector | Health | Health |
52-Week High | $209.48 | $3.27 |
52-Week Low | $147.06 | $2.30 |
Enterprise Value | $275.41B | $341.13M |
Dividend Yield | 2.01% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →
